Johnson & Johnson (JNJ)
225.33
-5.47
(-2.37%)
USD |
NYSE |
May 29, 16:00
225.35
+0.02
(+0.01%)
After-Hours: 20:00
Johnson & Johnson EPS Diluted (Quarterly) : 2.141 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Pfizer Inc. | 0.4688 |
| Bristol Myers Squibb Co. | 1.308 |
| Royalty Pharma Plc | 0.6738 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.235B |
| Revenue (Quarterly) | 24.07B |
| Total Expenses (Quarterly) | 18.83B |
| Enterprise Value | 575.35B |
| Gross Profit Margin (Quarterly) | 66.91% |
| Profit Margin (Quarterly) | 21.75% |
| Earnings Yield | 3.84% |
| Operating Earnings Yield | 4.73% |
| Normalized Earnings Yield | 4.131 |